vs
Aeries Technology, Inc.（AERT）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Aeries Technology, Inc.的54.4倍（$950.5M vs $17.5M）。Aeries Technology, Inc.净利率更高（6.6% vs 0.7%，领先5.9%）。Astrana Health, Inc.同比增速更快（42.9% vs -0.8%）。Aeries Technology, Inc.自由现金流更多（$2.1M vs $-6.0M）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -5.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
AERT vs ASTH — 直观对比
营收规模更大
ASTH
是对方的54.4倍
$17.5M
营收增速更快
ASTH
高出43.7%
-0.8%
净利率更高
AERT
高出5.9%
0.7%
自由现金流更多
AERT
多$8.1M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-5.9%
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $17.5M | $950.5M |
| 净利润 | $1.2M | $6.6M |
| 毛利率 | 19.1% | — |
| 营业利润率 | 4.4% | 1.9% |
| 净利率 | 6.6% | 0.7% |
| 营收同比 | -0.8% | 42.9% |
| 净利润同比 | -56.7% | 184.4% |
| 每股收益（稀释后） | $0.02 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AERTASTH
| Q4 25 | $17.5M | $950.5M | ||
| Q3 25 | $17.4M | $956.0M | ||
| Q2 25 | $15.3M | $654.8M | ||
| Q1 25 | $19.1M | $620.4M | ||
| Q4 24 | $17.6M | $665.2M | ||
| Q3 24 | $16.9M | $478.7M | ||
| Q2 24 | $16.7M | $486.3M | ||
| Q1 24 | $19.7M | $404.4M |
净利润AERTASTH
| Q4 25 | $1.2M | $6.6M | ||
| Q3 25 | $369.0K | $373.0K | ||
| Q2 25 | $1.6M | $9.4M | ||
| Q1 25 | $-6.0M | $6.7M | ||
| Q4 24 | $2.7M | $-7.8M | ||
| Q3 24 | $-2.3M | $16.1M | ||
| Q2 24 | $-14.7M | $19.2M | ||
| Q1 24 | $32.1M | $14.8M |
毛利率AERTASTH
| Q4 25 | 19.1% | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 24.6% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 24.1% | — | ||
| Q1 24 | 32.1% | — |
营业利润率AERTASTH
| Q4 25 | 4.4% | 1.9% | ||
| Q3 25 | 11.4% | 2.0% | ||
| Q2 25 | 5.3% | 3.1% | ||
| Q1 25 | -16.3% | 3.3% | ||
| Q4 24 | -29.3% | 0.1% | ||
| Q3 24 | -24.3% | 5.9% | ||
| Q2 24 | -98.5% | 6.2% | ||
| Q1 24 | -0.0% | 7.5% |
净利率AERTASTH
| Q4 25 | 6.6% | 0.7% | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 10.3% | 1.4% | ||
| Q1 25 | -31.6% | 1.1% | ||
| Q4 24 | 15.2% | -1.2% | ||
| Q3 24 | -13.5% | 3.4% | ||
| Q2 24 | -87.9% | 3.9% | ||
| Q1 24 | 163.1% | 3.7% |
每股收益（稀释后）AERTASTH
| Q4 25 | $0.02 | $0.12 | ||
| Q3 25 | $0.01 | $0.01 | ||
| Q2 25 | $0.03 | $0.19 | ||
| Q1 25 | $-0.10 | $0.14 | ||
| Q4 24 | $0.08 | $-0.14 | ||
| Q3 24 | $-0.05 | $0.33 | ||
| Q2 24 | $-0.39 | $0.40 | ||
| Q1 24 | — | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.6M | $429.5M |
| 总债务越低越好 | $943.0K | — |
| 股东权益账面价值 | $-1.2M | $779.3M |
| 总资产 | $42.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AERTASTH
| Q4 25 | $2.6M | $429.5M | ||
| Q3 25 | $1.9M | $463.4M | ||
| Q2 25 | $2.1M | $342.1M | ||
| Q1 25 | $2.8M | $260.9M | ||
| Q4 24 | $2.4M | $290.8M | ||
| Q3 24 | $3.6M | $350.3M | ||
| Q2 24 | $4.2M | $327.7M | ||
| Q1 24 | $2.1M | $337.3M |
总债务AERTASTH
| Q4 25 | $943.0K | — | ||
| Q3 25 | $960.0K | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $1.5M | — |
股东权益AERTASTH
| Q4 25 | $-1.2M | $779.3M | ||
| Q3 25 | $-2.9M | $775.5M | ||
| Q2 25 | $-4.3M | $765.5M | ||
| Q1 25 | $-5.8M | $745.4M | ||
| Q4 24 | $692.0K | $712.7M | ||
| Q3 24 | $-2.3M | $704.6M | ||
| Q2 24 | $-231.0K | $678.9M | ||
| Q1 24 | $-12.2M | $653.5M |
总资产AERTASTH
| Q4 25 | $42.0M | $2.2B | ||
| Q3 25 | $40.5M | $2.2B | ||
| Q2 25 | $38.8M | $1.4B | ||
| Q1 25 | $39.8M | $1.3B | ||
| Q4 24 | $50.7M | $1.4B | ||
| Q3 24 | $52.0M | $1.3B | ||
| Q2 24 | $51.8M | $1.3B | ||
| Q1 24 | $49.4M | $1.2B |
负债/权益比AERTASTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.17× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.4M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $2.1M | $-6.0M |
| 自由现金流率自由现金流/营收 | 12.2% | -0.6% |
| 资本支出强度资本支出/营收 | 1.3% | 0.3% |
| 现金转化率经营现金流/净利润 | 2.05× | -0.44× |
| 过去12个月自由现金流最近4个季度 | $4.6M | $104.5M |
8季度趋势，按日历期对齐
经营现金流AERTASTH
| Q4 25 | $2.4M | $-2.9M | ||
| Q3 25 | $1.0M | $10.0M | ||
| Q2 25 | $1.4M | $90.9M | ||
| Q1 25 | $864.0K | $16.6M | ||
| Q4 24 | $-2.1M | $-10.9M | ||
| Q3 24 | $1.9M | $34.0M | ||
| Q2 24 | $-1.7M | $23.2M | ||
| Q1 24 | $-3.0M | $6.0M |
自由现金流AERTASTH
| Q4 25 | $2.1M | $-6.0M | ||
| Q3 25 | $653.0K | $7.4M | ||
| Q2 25 | $1.1M | $89.5M | ||
| Q1 25 | $752.0K | $13.6M | ||
| Q4 24 | $-2.5M | $-13.5M | ||
| Q3 24 | $1.3M | $31.7M | ||
| Q2 24 | $-2.1M | $20.4M | ||
| Q1 24 | $-3.5M | $5.6M |
自由现金流率AERTASTH
| Q4 25 | 12.2% | -0.6% | ||
| Q3 25 | 3.8% | 0.8% | ||
| Q2 25 | 7.2% | 13.7% | ||
| Q1 25 | 3.9% | 2.2% | ||
| Q4 24 | -14.0% | -2.0% | ||
| Q3 24 | 7.8% | 6.6% | ||
| Q2 24 | -12.5% | 4.2% | ||
| Q1 24 | -17.6% | 1.4% |
资本支出强度AERTASTH
| Q4 25 | 1.3% | 0.3% | ||
| Q3 25 | 2.1% | 0.3% | ||
| Q2 25 | 1.7% | 0.2% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 2.2% | 0.4% | ||
| Q3 24 | 3.6% | 0.5% | ||
| Q2 24 | 2.2% | 0.6% | ||
| Q1 24 | 2.3% | 0.1% |
现金转化率AERTASTH
| Q4 25 | 2.05× | -0.44× | ||
| Q3 25 | 2.78× | 26.69× | ||
| Q2 25 | 0.87× | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | -0.78× | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | -0.09× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AERT
暂无分部数据
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
